You are leaving this website. By clicking ACCEPT, you will be re-directed to a third-party website. Cosette Pharmaceuticals assumes no responsibility for the content of the website(s). Once You click ACCEPT and leave our Website, the Terms of Use and Privacy Policy will immediately cease to apply to any subsequent activity on the other website. Cosette Pharmaceuticals assumes no liability for any damages or injuries of any kind arising third party website(s). Click ACCEPT if you wish to proceed.

logo
Newsroom Careers Contact Us
  • COMPANY
  • PEOPLE
  • PRODUCTS
    • Brands
    • Generic
    • OTC
  • COSETTE CDMO
    • Manufacturing & Packaging
    • Technical Services & Quality
  • COSETTE CARES
  • PARTNERSHIPS

Now Available CLOMID™ (clomiphene citrate) 50mg Tablets in 10 and 30 count boxes

October 7, 2022

BRIDGEWATER, NJ – OCTOBER 7, 2022:

RECENT POSTS

Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel

April 28, 2026

Cosette Pharmaceuticals Appoints Danielle DeBoer as Senior Vice President, Human Resources

April 14, 2026

Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio

April 8, 2026

Cosette Pharmaceuticals Appoints Joseph Skelton as Senior Vice President, Corporate Development and Strategy

March 18, 2026

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivity

December 16, 2025

Innovating every day.™

Please sign up to our news alerts. Once you’ve submitted your request, you will receive your activation link by email.

    Sign up for Press Releases



    ©2026 Cosette Pharmaceuticals

    Our CompanyOur PeopleOur ProductsPartnershipsCareersNewsroomContact UsTerms of UsePrivacy PolicyConsent Preferences

    Cosette Pharma
    • Home
    • Our Company
    • Our People
    • Products
      • — Brands —
      • — Generic —
      • — OTC —
    • Partnerships
    • Careers
    • Newsroom
    • Contact Us
    • Terms Of Use
    • Privacy Policy

    Privacy Preference Center

    Privacy Preferences

    Cosette Pharmaceuticals has received reports of employment scams in recent months that often seek financial and personally identifiable information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts from individuals purporting to be or represent Cosette employees. This usually leads to “online interviews” conducted via teleconference applications for virtual positions within the company that do not actually exist. Please be advised that Cosette does not extend unsolicited employment offers and does not utilize chat rooms or ask for financial information during the interview process.

    If you would like to pursue employment opportunities with Cosette, please visit our official career website at: www.cosettepharma.com

    • You may report any potential scams to customerservice@cosettepharma.com.
    • You should also report the activity to the Internet Crime Complaint Center at ic3.gov, FTC Fraud Center at www.reportfraud.ftc.gov or your local FBI field office.
    • If you reveal your financial information, contact your financial institution immediately and direct them to stop or reverse the transactions.
    • Ask your financial institution to contact the corresponding financial institution where the fraudulent or suspicious transfer was sent.